EMS Today

EMS is the largest pharmaceutical company in Brazil and a dominant force in the Latin American healthcare market. Established in 1964, the company specializes in the development, manufacturing, and commercialization of a wide range of products, including generics, branded prescription drugs, and over-the-counter medicines. EMS has a strong focus on innovation, investing heavily in its R&D centers and participating in the Bionovis joint venture to develop high-complexity biotechnological products and biosimilars. The company's portfolio covers diverse therapeutic areas such as cardiology, oncology, and central nervous system disorders, supported by state-of-the-art manufacturing facilities that meet international quality standards.